InDex Pharmaceuticals discontinues cobitolimod phase III program
/PRNewswire/ -- InDex Pharmaceuticals Holding AB (publ) ("InDex Pharmaceuticals") today announces that an independent DMC has completed the planned dose...
Source: prnewswire.com
Johan Gil News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Johan Gil. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Johan Gil Today - Breaking & Trending Today
InDex Pharmaceuticals discontinues cobitolimod phase III program
STOCKHOLM, Nov. 21, 2023 /PRNewswire/ -- InDex Pharmaceuticals Holding AB (publ) ("InDex Pharmaceuticals")...
Source: europapress.es
InDex Pharmaceuticals discontinues cobitolimod phase III program
/PRNewswire/ -- InDex Pharmaceuticals Holding AB (publ) ("InDex Pharmaceuticals") today announces that an independent DMC has completed the planned dose...
Source: prnewswire.com
InDex Pharmaceuticals has been granted a new patent for cobitolimod in South Korea
/PRNewswire/ -- InDex Pharmaceuticals Holding AB (publ) today announced that a new method of use patent for the drug candidate cobitolimod has been granted by...
Source: prnewswire.com
InDex Pharmaceuticals announces that all patients needed for the cobitolimod dose selection milestone have completed Ind
STOCKHOLM, Oct. 11, 2023 /PRNewswire/ -- InDex Pharmaceuticals Holding AB (publ) today announced that 30% of...
Source: europapress.es